Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β(2) agonist vilanterol administered once daily for 52 weeks in patients ≥12...

por Busse, William W, O'Byrne, Paul M, Bleecker, Eugene R, Lötvall, Jan, Woodcock, Ashley, Andersen, Leslie, Hicks, Wesley, Crawford, Jodie, Jacques, Loretta, Apoux, Ludovic, Bateman, Eric D
Publicado 2013